Predicting and Improving Critical Outcomes for Bacterial Keratitis |
Nisha Acharya, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Macular Edema Treatment Trials Associated with MUST (META-MUST) |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
F.I. Proctor Foundation Uveitis Fellowship training program |
Nisha Acharya, MD |
Eye Disease and Blindness, Training and Capacity Building |
|
|
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Trial (ADJUST) |
Nisha Acharya, MD |
Eye Disease and Blindness, Immunology |
|
|
Mycotic Ulcer Treatment Trial (MUTT) |
Nisha Acharya, MD |
Infectious Disease, Eye Disease and Blindness |
|
|
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial |
Nisha Acharya, MD |
Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Fellowship - Award - 2016-2017 Pathogenesis and Treatment of Ebola-Associated Uveitis Rationale |
Nisha Acharya, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis |
Nisha Acharya, MD |
Eye Disease and Blindness |
|
|
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial |
Nisha Acharya, MD |
Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE) Trial |
Nisha Acharya, MD |
Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
Macular Edema Treatment Trials Associated with MUST (META-MUST) |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Clinical Research Fellowship for Nisha Acharya |
Nisha Acharya, MD |
Eye Disease and Blindness |
|
|
Effect of Ranibizumab on Refractory Macular Edema in Uveitis Phase I/II |
Nisha Acharya, MD |
Eye Disease and Blindness |
|
|
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis |
Nisha Acharya, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Multicenter Study in treating Macular Edema |
Nisha Acharya, MD |
Eye Disease and Blindness |
|
|
Iontophoresis Delivery of Dexamethason Phosphate for Non-Infectious, No-Necrotizing Anterior Scieritis, Phase I Dose-Varying Study |
Nisha Acharya, MD |
Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
Multicenter Uveitis Steroid Treatment (MUST) Trial |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma |
|
Eye Disease and Blindness |
|
|
Immunologic determinants of age-related macular degeneration |
Peter Hunt, MD |
Eye Disease and Blindness, Immunology, Aging |
|
|
Planning Grant for Parasitic Ulcer Treatment Trial |
Jeremy Keenan, MD, MPH |
Eye Disease and Blindness |
|
|
Village-Integrated Eye Worker trial II (VIEW II) |
Jeremy Keenan, MD, MPH |
Eye Disease and Blindness, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
Optimal Trachoma Control after Mass Antibiotic Distributions |
Jeremy Keenan, MD, MPH |
Eye Disease and Blindness |
|
|
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) |
Jeremy Keenan, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Village Integrated Eye Worker Trial II - Keenan/Carl Zeiss Meditec |
Jeremy Keenan, MD, MPH |
Eye Disease and Blindness |
|
|
CDA - Improving the Diagnosis and Treatment of Acanthamoeba Keratitis |
Jeremy Keenan, MD, MPH |
Eye Disease and Blindness |
|
|
Studies of Ocular Complications of AIDS (SOCA) |
|
HIV/AIDS, Eye Disease and Blindness |
|
|
Digital Detection of Infectious Eye Epidemics |
Thomas Lietman, MD |
Eye Disease and Blindness |
|
|
Research to Programs for Trachoma Elimination |
Thomas Lietman, MD |
Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance |
|
|
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial |
Thomas Lietman, MD |
Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
Forecasting Trachoma Control |
Thomas Lietman, MD |
Eye Disease and Blindness, Epidemiology and Surveillance, Global Strategic Information |
|
|
Quantitative analysis and modelling on targets and strategies for alleviating the burden of priority neglected tropical diseases |
Thomas Lietman, MD |
Eye Disease and Blindness |
|
|
Mortality Reduction After Oral Azithromycin |
Thomas Lietman, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Epidemiology and Surveillance |
|
|
Mycotic Ulcer Treatment Trial |
Thomas Lietman, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
Village Integrated Eye Workers Trial |
Thomas Lietman, MD |
Eye Disease and Blindness |
|
|
Planning Grant for a large scale azithromycin trial for prevention of under-5 mortality in Niger |
Thomas Lietman, MD |
Malaria, Eye Disease and Blindness, Pediatrics |
|
|
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma |
Thomas Lietman, MD |
Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance |
|
|
The Steroids for Corneal Ulcers Trial |
Thomas Lietman, MD |
Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
TANA II |
Thomas Lietman, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance |
|
|
Infectious and inflammatory eye disease epidemic detection and seasonality |
Thomas Lietman, MD |
Eye Disease and Blindness |
|
|
Tools for the Endgame: Accelerating the development and introduction of Dx to Support the London Declaration 2020 goals for Neglected Tropical Diseases (NTDs) |
Thomas Lietman, MD |
Neglected Tropical Diseases (NTDs), Eye Disease and Blindness |
|
|
Predicting Resistance: Validating Mathematical Models |
Thomas Lietman, MD |
Eye Disease and Blindness, Epidemiology and Surveillance |
|
|
Village Integrated Eye Workers Trial |
Thomas Lietman, MD |
Infectious Disease, Eye Disease and Blindness, Risk Reduction and Prevention |
|
|
Eliminating Trachoma with Repeat Mass Drug Treatment |
Thomas Lietman, MD |
Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
What is the Appropriate Frequency and Duration of Mass Azithromycin |
Thomas Lietman, MD |
Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
Trachoma control in Africa through mass antibiotic administration, and corneal ulcer prevention and treatment in South Asia |
Thomas Lietman, MD |
Infectious Disease, Eye Disease and Blindness |
|
|
Strategies for the Control and Elimination of Blinding Trachoma |
Thomas Lietman, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness |
|
|
Elimination of Infectious Trachoma from Ethiopia Using Repeated Mass Antibiotic Distributions |
Thomas Lietman, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness |
|
|
Modeling Contact Investigation and Rapid Response |
Travis Porco, PhD, MPH |
Eye Disease and Blindness |
|
|
Epidemiology of infectious disease |
Travis Porco, PhD, MPH |
Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance |
|
|
A point of care assay for chlamydia to assure prompt treatment in at risk minorities |
Julius Schachter, PhD |
Infectious Disease, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Processing Uganda Swabs for Trachoma Alternative Indicators Study |
Julius Schachter, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Detection of C. trachomatis on eye swabs |
Julius Schachter, PhD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Epidemiology and clinical manifestations of chlamydial infections |
Julius Schachter, PhD |
Eye Disease and Blindness |
|
|
Sjögren International Collaborative Clinical Alliance (SICCA) Biorepository |
Caroline Shiboski, DDS, MPH, PhD |
Eye Disease and Blindness, Oral Health |
|
|
Sjögren’s International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen) |
Caroline Shiboski, DDS, MPH, PhD |
Eye Disease and Blindness, Oral Health |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
Nanoporous Films for Ocular Drug Delivery |
Tejal Desai, PhD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
High Resolution Retinal Imaging in Patients with Age-Related Macular Degeneration and other Retinal Degenerative Diseases |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Noninvasive Assessment of Photoreceptor Structure and Function in Retinitis Pigmentosa with Adaptive Optics Scanning Laser Ophthalmoscopy |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Mactel Natural History Observation and Registry Study |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Molecular Basis of Hereditary Retinal Degenerations |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) |
Jacque Duncan, MD |
Eye Disease and Blindness, Pharmacology and Drug Treatment |
|
|
The relationship between structure and function in inherited retinal disease |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Assessment of cone structure and function with high resolution in eyes with retinal degeneration |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
NDC for the Optical Control of Biological Function |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
New Enrollment Post-Approval Study of the Argus II Retinal Prosthesis System |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Studies of the Ocular Complications of AIDS (SOCA) |
Jacque Duncan, MD |
HIV/AIDS, Eye Disease and Blindness |
|
|
Advanced Technology to Study Visual Function on a Cellular Scale |
Jacque Duncan, MD |
Eye Disease and Blindness |
|
|
Signal Processing in the Retina |
|
Eye Disease and Blindness |
|
|
Eliminating Trachoma with Repeat Mass Drug Treatment |
|
Eye Disease and Blindness |
|
|
Regulation of Herpes Simplex Type 1 Infection in Corneal Neurons |
|
Eye Disease and Blindness |
|
|
Characterization of TRPM1 isoforms and binding partners in ON bipolar cells |
|
Eye Disease and Blindness |
|
|
Predictors of Response to Treatment in Fungal Keratitis |
Jennifer Rose-Nussbaumer, MD |
Eye Disease and Blindness |
|
|
RPB Unrestricted Grant |
Stephen Mcleod, MD |
Eye Disease and Blindness |
|
|
The Efficacy of Topically Applied Nepafenac in Prolonging Mydriasis in a Model of Phacoemusification |
Stephen Mcleod, MD |
Eye Disease and Blindness |
|
|
Center for the Child with Visual Disabilities |
Stephen Mcleod, MD |
Eye Disease and Blindness, Pediatrics |
|
|
UCSF RPB Unrestricted Grant Application |
Stephen Mcleod, MD |
Infectious Disease, Eye Disease and Blindness |
|
|
2007 Horizon Grants Program - Retina |
Stephen Mcleod, MD |
Eye Disease and Blindness, Residencies, Fellowships, and Postdoctoral Training |
|
|
2008 Horizon Grants Program - F.I. Proctor Fellowship |
Stephen Mcleod, MD |
Eye Disease and Blindness, Residencies, Fellowships, and Postdoctoral Training |
|
|
UCSF RPB Unrestricted Grant Application |
Stephen Mcleod, MD |
Infectious Disease, Eye Disease and Blindness |
|
|
Diagnosis and treatment of infectious keratitis |
Stephen Mcleod, MD |
Infectious Disease, Eye Disease and Blindness |
|
|
Impact of Antibiotics on the Ocular Surface Microbiome and Ophthalmic Infectious Diseases |
Thuy Doan, MD, MPH |
Eye Disease and Blindness |
|
|
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health |
Thuy Doan, MD, MPH |
Eye Disease and Blindness |
|
|
Improving the quality of refractive eye care services provided in outreach camps and primary care centers in India: a mixed methods study |
Talita Rosa, MD |
Eye Disease and Blindness |
|
|
Closing the Primary Eye Care Gap in Southern India |
Jamen Garcia, MS |
Eye Disease and Blindness |
|
|
Kebele Elimination of Trachoma for Ocular Health |
Catherine Oldenburg, ScD, MPH |
Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance |
|
|
Targeted Azithromycin Strategies for Trachoma Elimination in Ethiopia |
Catherine Oldenburg, ScD, MPH |
Eye Disease and Blindness, Epidemiology and Surveillance |
|
|
Chlamydial sexually transmitted diseases and trachoma |
Deborah Dean, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Trachoma in Southwestern Nepal |
Deborah Dean, MD, MPH |
Infectious Disease, Eye Disease and Blindness |
|
|
Effectiveness of Tele-ophthalmology on Eye Care in Rural Southern India |
Rachel Chung, MS |
Eye Disease and Blindness, Training International Scholars and Clinicians |
|
|
Seroepidemiologic methods to identify hotspots of trachoma and predict future infection |
Benjamin F. Arnold, PhD |
Eye Disease and Blindness, Epidemiology and Surveillance |
|
|